Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBM Psyence Biomedical Ltd

Pre-Mkt 10-13 09:19:21 EDT

4.74

-0.23

-4.63%

盘前4.72

-0.02-0.42%

09:17 EDT

High5.04	Low4.73	Vol25.43K
Open4.88	D1 Closing4.97	Amplitude6.25%
Mkt Cap18.08M	Tradable Cap5.19M	Total Shares3.81M
T/O122.32K	T/O Rate2.32%	Tradable Shares1.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":4.74,"timestamp":1791835200000,"preClose":4.97,"halted":0,"volume":25432,"hourTrading":{"tag":"盘前","latestPrice":4.72,"preClose":4.74,"latestTime":"09:17 EDT","volume":1232,"amount":5694.119815999999,"timestamp":1791897478314,"change":-0.02,"changeRate":-0.004219,"amplitude":0.027426},"delay":0,"changeRate":-0.04627766599597576,"floatShares":1094600,"shares":3814300,"eps":-12.559563,"marketStatus":"Pre-Mkt","change":-0.23,"latestTime":"10-13 09:19:21 EDT","open":4.88,"high":5.0407,"low":4.73,"amount":122321.027928,"amplitude":0.062515,"askPrice":5.45,"askSize":100,"bidPrice":3.5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-12.559563,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":4.74,"preHourTrading":{"tag":"盘前","latestPrice":4.72,"preClose":4.74,"latestTime":"09:17 EDT","volume":1232,"amount":5694.119815999999,"timestamp":1791897478314,"change":-0.02,"changeRate":-0.004219,"amplitude":0.027426},"postHourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.74,"latestTime":"19:30 EDT","volume":127,"amount":607.89,"timestamp":1791847801948,"change":0.06,"changeRate":0.012658,"amplitude":0.012658},"volumeRatio":0.4171560159172472},"requestUrl":"/m/hq/s/PBM/tweets","defaultTab":"tweets","newsList":[{"id":"2673704346","title":"Psyence Biomedic - Texas Ibogaine Research Corp Enters Manufacturing Partnership with Benuvia for U.S. Ibogaine API","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704346?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:02","pubTimestamp":1791198155,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R045:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704312","title":"Psyence Biomedic - Tirc and Psylabs to Conclude Definitive Agreement by November 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704312?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:02","pubTimestamp":1791198155,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R045:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673343704","title":"Psyence Biomedical Ltd: Partners with Dea-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine","url":"https://stock-news.laohu8.com/highlight/detail?id=2673343704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673343704?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:02","pubTimestamp":1791198124,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R044:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704326","title":"Psyence BioMed Partners with Benuvia to Make Pharmaceutical-Grade Ibogaine in Texas","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704326","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704326?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:02","pubTimestamp":1791198122,"startTime":"0","endTime":"0","summary":"Psyence BioMed partners with Benuvia to make pharmaceutical-grade ibogaine in TexasPsyence Biomedical’s Texas unit, Texas Ibogaine Research Corp, signed a manufacturing services agreement with Benuvia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL8wJ5yr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239722","title":"Psyence BioMed Unit Signs Term Sheet with PsyLabs for Exclusive U.S. Ibogaine License, Supply Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239722","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239722?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:01","pubTimestamp":1790593316,"startTime":"0","endTime":"0","summary":"Psyence BioMed unit signs term sheet with PsyLabs for exclusive U.S. ibogaine license, supply dealPsyence Biomedical entered a binding term sheet with PsyLabs for exclusive U.S. rights to pharmaceutic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLR3YvJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239287","title":"Psyence Biomedical - Definitive Agreement for Exclusive U.S. Ibogaine License Expected by November 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239287","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239287?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:00","pubTimestamp":1790593237,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I02I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670223928","title":"Psyence Biomed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2670223928","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670223928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:00","pubTimestamp":1790593237,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I02I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438387","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438387","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669438387?lang=en_us&edition=fundamental","pubTime":"2026-09-24 01:11","pubTimestamp":1790183493,"startTime":"0","endTime":"0","summary":"Beneficient  said Wednesday it has launched a strategy to eliminate fraudulent debt asserted by HCLP Nominees alongside equity interests owned by former Chief Executive Brad Heppner.Shares surged roughly328% as intraday trading volume catapulted to more than 235 million from a daily average of about 4 million.Psyence Biomedical  shares were up about 11% after the company said it agreed to invest as much as $5 million in cash into Psyence Labs alongside an equal-value share exchange.More than 237,000 shares traded intraday versus a daily average of roughly 86,800.NN  said Tuesday it raised its full-year 2026 guidance ranges for net sales to $470 million to $490 million from $460 million to $480 million and for adjusted EBITDA to $58 million to $68 million from $55 million to $65 million.Shares rose past 11% as intraday trading volume surged past 5.5 million from an average of around 3.8 million.Price: 2.18, Change: +1.64, Percent Change: +305.03","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBM","BK4135","BK4161","BK4139","NNBR","BENF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669397488","title":"Psyence Biomedical announces strategic Ibogaine investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669397488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669397488?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:16","pubTimestamp":1790162162,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) announced that it has agreed to make a cash investment of up to $5M in Psyence Labs, together with a value-matched share e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-announces-strategic-ibogaine-investment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-announces-strategic-ibogaine-investment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669100973","title":"Psyence Biomedical - Co and Psylabs Agree to $9 Mln Value-Matched Share Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2669100973","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669100973?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161250,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0M8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669100166","title":"Psyence Biomedical - Post-Deal, Psylabs to Hold 49.89% of Psyence Biomed, Psyence Biomed 41.13% of Psylabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669100166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669100166?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161250,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0M8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669009781","title":"Psyence Biomedical -Agrees to Invest up to $5 Mln in Psylabs, $2.40 Mln Committed","url":"https://stock-news.laohu8.com/highlight/detail?id=2669009781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669009781?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161250,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0M8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669006081","title":"Psyence Biomed Announces Strategic Ibogaine Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669006081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669006081?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161250,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0M8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669002291","title":"Press Release: Psyence BioMed Announces Strategic Ibogaine Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669002291","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669002291?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161200,"startTime":"0","endTime":"0","summary":"Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchangeHighlights-- The Company is actively advancing plans for a potential ibogaine clinical. trial in Texas for Opioid Use Disorder .-- Texas Ibogaine Research Corporation , a dedicated U.S. subsidiary. of Psyence BioMed, has been established for its planned ibogaine. which US$2.4 million has been committed, to support scientific. -- Psyence BioMed and PsyLabs have agreed to a value-matched share exchange","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","PBM","BK4139","EES","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862533","title":"As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862533?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:16","pubTimestamp":1789485372,"startTime":"0","endTime":"0","summary":"The strongest evidence for use of the drugs so far has come from trials in patients with severe depression or post-traumatic stress disorder who have not responded to existing treatments.Early-stage trials are also testing psychedelic drugs for substance abuse disorders, borderline personality disorder, obsessive-compulsive disorders, anxiety, self-harm behavior, chronic Lyme disease and fibromyalgia.HOW DO PSYCHEDELIC TREATMENTS WORK?Psychedelic treatments work primarily by activating proteins on the surface of nerve cells that regulate the brain's ability to reorganize, form new connections, and repair damaged circuits. Unlike traditional psychiatric drugs that may be taken at home on a daily basis, these treatments are usually administered by medical personnel in a limited number of sessions to supplement intensive psychotherapy.WHAT PSYCHEDELIC DRUGS ARE CURRENTLY AUTHORIZED FOR USE?In the U.S. and Europe, the leading candidate for authorization is psilocybin, the active ingredient","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","IE0001KFT4U8.USD","LU1496350502.SGD","LU1121112475.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0912757837.SGD","SG9999002232.USD","LU2129689605.HKD","LU1732800096.USD","LU2505996509.AUD","SG9999013999.USD","SGXZ57979304.SGD","LU1551013342.USD","LU2213496289.HKD","LU0162691827.USD","IE0009355771.USD","BMED","LU0889566641.SGD","BK4007","LU2756315664.SGD","LU0466842654.USD","LU0795875086.SGD","LU2471134952.CNY","IE00BFTCPJ56.SGD","LU1629891620.HKD","LU2896262040.SGD","LU0345769128.USD","LU0820561818.USD","LU2430703095.HKD","BK4559","LU0234570918.USD","LU0345770993.USD","IE000SO60NU8.SGD","LU1674673428.USD","LU1551013425.SGD","LU2487616109.SGD","IHE","LU0053666078.USD","IE00B3T34201.USD","IE000F7OJYX1.SGD","IE00BFXG1179.USD","LU0210528500.USD","IE000BZT7R73.USD","LU1023059063.AUD","LU0210536198.USD","LU1244550221.USD","LU1267930813.SGD","LU1989771016.USD","LU2236285917.USD","LU0432979614.USD","TRUH","LU2750360997.AUD","BK4581","IE00B2B36J28.USD","LU0057025933.USD","LU0683600562.USD","LU1674673691.USD","LU1983299246.USD","IE0000B7K699.USD","FTXH","LU0345770308.USD","LU1059921491.USD","LU1929549753.HKD","LU1585245621.USD","IE00BJT1NW94.SGD","SG9999002224.SGD","LU0098860793.USD","LU0320765646.SGD","LU0985320562.USD","LU2471134796.USD","LU0994945656.USD","LU1228905037.USD","CMPS","LU1032466523.USD","IE00BN8TJ469.HKD","IE0002270589.USD","BK4585","LU0124676726.USD","LU0345769631.USD","IE00B7SZLL34.SGD","LU1162221912.USD","LU1066051225.USD","PSIL","BK4139","IXJ","SGXZ80539844.SGD","LU1074936037.SGD","IE000WAW04H5.SGD","LU0289739699.SGD","LU1506573853.SGD","IE00BGHQF631.EUR","PBM","LU1221951046.USD","IE00BJJMRZ35.SGD","LU1244550577.SGD","LU1894683348.USD","PJP","BK4588","LU1066051811.HKD","BK4504","IE00BDGV0183.EUR","LU0545562505.USD","LU1145028129.USD","JNJ","IE0002141913.USD","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","LU0426417589.USD","SG9999001440.SGD","LU0820562030.AUD","LU0795875169.SGD","IE000M9KFDE8.USD","LU0689626769.HKD","LU0234572021.USD","RXL","LU2133065610.SGD","LU1196500208.SGD","LU2750360641.GBP","LU1261432733.SGD","BK4550","LU2471134879.HKD","FHLC","LU1430594728.SGD","LU2602419157.SGD","IE00BVYPNW00.USD","LU1066053197.SGD","GDOC","LU2505996681.GBP","LU1244550494.USD","LU0820561909.HKD","BK4568","LU0114720955.EUR","LU1221951129.SGD","LU2456880835.USD","LU1894683264.USD","BK4532","LU1032955483.USD","IE00B1BXHZ80.USD","LU1935042991.SGD","IE00BLSP4452.SGD","LU2403377893.USD","JDOC","LU1778281490.HKD","LU2347655156.SGD","LU0069063385.USD","BK4534","LU0787776722.HKD","LU0203345920.USD","VHT","IE00B3PB1722.GBP","LU0964807845.USD","LU2129689431.USD","IYH","IE0034235303.USD","LU1043141396.HKD","LU1718418525.SGD","LU0203347892.USD","LU2468319806.SGD","IE00BVYPNV92.GBP","LU0072461881.USD","LU1291159041.SGD","LU1057294990.SGD","LU2089984988.USD","LU2430703251.USD","LU1061106388.HKD","IE00BSNM7G36.USD","LU2417539215.USD","LU1043141123.HKD","BK4592","LU0689472784.USD","LU0426412945.USD","BK4533","LU2023250330.USD","LU2129689514.USD","LU0472753341.HKD","LU0943347566.SGD","LU0882574055.USD","LU2112291526.USD","LU0640476718.USD","LU0289961442.SGD","IE00B42XCP33.USD","IE00BLSP4239.USD","MEDX","LU0122379950.USD","LU0070217475.USD","LU1228905540.USD","LU2430703178.SGD","SG9999001176.USD","XLV","LU2756315318.SGD","LU2471134523.USD","LU0792757196.USD","LU0058720904.USD","LU1280957306.USD","IE00BZ1G4Q59.USD","LU0511384066.AUD","LU0289739343.SGD","LU1066051498.USD","SG9999001176.SGD","LU1732799900.SGD","LU2592432038.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668175","title":"Psyence Biomedical establishes Texas Ibogaine Research Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668175?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:10","pubTimestamp":1789384224,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) announced the formation of Texas Ibogaine Research Corporation, or TIRC, a Texas-based company established to coordinate t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-establishes-texas-ibogaine-research-corporation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-establishes-texas-ibogaine-research-corporation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668853","title":"Psyence BioMed Names John Thorne Project Lead at New Texas Ibogaine Unit TIRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668853","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668853?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:02","pubTimestamp":1789383755,"startTime":"0","endTime":"0","summary":"Psyence BioMed names John Thorne project lead at new Texas ibogaine unit TIRCPsyence Biomedical formed Texas Ibogaine Research Corporation as a dedicated U.S. vehicle for its ibogaine development prog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL7VGhtp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","PBM","BK4139","SG9999014039.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BK4112","IE00B3QW5Z07.USD","BCDF","IE00B64PRP62.GBP","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","NDAQ","IE00BN0W2T93.GBP","BK4588","BK4585","LU0314104364.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660960964","title":"NASDAQ Trade Halt Volatility Trading Pause at 12:58 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2660960964","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660960964?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:58","pubTimestamp":1787072282,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 12:58 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nAQN2MFDX4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111460","title":"Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111460","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111460?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:30","pubTimestamp":1783945800,"startTime":"0","endTime":"0","summary":"Companion Animal Health CT-RevitL   Companion Animal Health CT-RevitL, the next-generation laser therapy system for veterinary care.  CT-RevitL launches in the United States, built on a foundation of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326176/0/en/Enovis-Companion-Animal-Health-Launches-CT-RevitL-the-Next-Generation-Laser-Therapy-System-for-Veterinary-Care.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","IE00B19Z6F94.USD","ENOV","PBM","IE0034390439.USD","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645945077","title":"Psyence Biomedical FY26 net loss widens to about USD 6.89 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2645945077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645945077?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:02","pubTimestamp":1782158561,"startTime":"0","endTime":"0","summary":"Psyence Biomedical posted a net loss of about USD 6.89 million for fiscal 2026, remaining pre-revenue with no revenue from product sales.R&D expense more than doubled to USD 1.47 million, reflecting accelerated activity in its Phase IIb psilocybin trial in palliative care patients.Professional and consulting fees climbed to USD 3.65 million, while the company recorded a USD 1.5 million net settlement expense tied to the KAOS Group dispute.Cash rose to USD 7.49 million, lifting working capital to USD 8.49 million; an Australian R&D cash rebate of USD 292,247 was received.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data G","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL1Fjv6r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pacificbooker.bc.ca","stockEarnings":[{"period":"1week","weight":-0.0669},{"period":"1month","weight":-0.1222},{"period":"3month","weight":0.6516},{"period":"6month","weight":0.6458},{"period":"1year","weight":-0.7899},{"period":"ytd","weight":0.0066}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.1915},{"period":"ytd","weight":0.141}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.237918},{"month":2,"riseRate":0.4,"avgChangeRate":-0.252579},{"month":3,"riseRate":0.6,"avgChangeRate":0.107838},{"month":4,"riseRate":0.6,"avgChangeRate":0.247702},{"month":5,"riseRate":0.4,"avgChangeRate":-0.036399},{"month":6,"riseRate":0.6,"avgChangeRate":-0.15148},{"month":7,"riseRate":0.8,"avgChangeRate":0.19189},{"month":8,"riseRate":0.6,"avgChangeRate":-0.071106},{"month":9,"riseRate":0.8,"avgChangeRate":-0.071252},{"month":10,"riseRate":0.2,"avgChangeRate":-0.089804},{"month":11,"riseRate":0.25,"avgChangeRate":-0.211015},{"month":12,"riseRate":0.25,"avgChangeRate":-0.267978}],"exchange":"NASDAQ","name":"Psyence Biomedical Ltd","nameEN":"Psyence Biomedical Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Psyence Biomedical Ltd,PBM,Psyence Biomedical Ltd股票,Psyence Biomedical Ltd股票老虎,Psyence Biomedical Ltd股票老虎国际,Psyence Biomedical Ltd行情,Psyence Biomedical Ltd股票行情,Psyence Biomedical Ltd股价,Psyence Biomedical Ltd股市,Psyence Biomedical Ltd股票价格,Psyence Biomedical Ltd股票交易,Psyence Biomedical Ltd股票购买,Psyence Biomedical Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}